Attention spans are dropping, research shows: Here's how to help keep focused
Feel like you can't focus? Like you'll never finish a book again? Like the only way to keep your mind and hands busy is to scroll on social media for hours?
You're far from alone.
One body of decades-long research found the average person's attention span for a single screen is 47 seconds, down from 2.5 minutes in 2004.
Advertisement
4 Decades-long research indicates how the average attention span for a single screen is 47 seconds, down from 2.5 minutes in 2004.
Rawpixel.com – stock.adobe.com
The 24/7 news cycle, uncertainty about the state of the world and countless hours of screen time don't help, experts say.
'When my patients talk to me about this stuff there is often a feeling of helplessness or powerlessness,' said Dr. Michael Ziffra, a psychiatrist at Northwestern Medicine. 'But you can change these behaviors. You can improve your attention span.'
Here are ways to start that process.
Advertisement
As you read, challenge yourself to set a 2.5 minute timer and stay on this article without looking at another device or clicking away.
How did we lose focus?
A shifting attention is an evolutionary feature, not a bug. Our brains are hardwired to quickly filter information and hone in on potential threats or changes in what's happening around us.
What's grabbing our attentions has changed. For our ancestors, it might have been a rustle in the bushes putting us on guard for a lurking tiger. Today, it could be a rash of breaking news alerts and phone notifications.
Advertisement
4 According to clinical psychologist Stacey Nye, the COVID-19 pandemic impacted people's sense of time, increasing screentime.
zvkate – stock.adobe.com
The COVID-19 pandemic warped many people's sense of time and increased their screen usage like never before, said Stacey Nye, a clinical psychologist at the University of Wisconsin-Milwaukee.
Technology isn't the only thing that influences our attention, experts say, but the effects of those pinging notifications or hours scrolling through 30-second long videos can build up over time.
'Our attention span has really been trained to only focus in those little, small blips and it interrupts our natural focus cycles,' she said.
Give your wandering mind 'active breaks'
Advertisement
Experts say 'active' breaks are among the best way to retrain your mind and your attention. They only take about 30 minutes, Nye said, and can be as simple as taking a walk while noticing things around you or moving to another room for lunch.
Don't be afraid to get creative. Develop a list of alternative activities or randomly choose ideas out of a fish bowl. Try craft projects, a short meditation, fixing a quick meal or talking a walk outside. All the better if you can involve a friend as well.
The break needs to be a physical or mental activity — no passive phone-scrolling.
When the brain is understimulated and looking for change, it'll usually grab onto the first thing it sees. The smartphone, an 'ever-producing change machine,' is an enticing option, said Cindy Lustig, a cognitive neuroscientist at the University of Michigan.
4 Taking breaks can help refocus your attention.
dikushin – stock.adobe.com
Turn off unnecessary notifications and put that 'do not disturb' mode to good use, especially before bedtime. Better yet, put your phone in a whole different room, Lustig said.
Say no to multitasking
Multitasking may make you feel like you're getting more done, but brain experts recommend against it.
Advertisement
'Be a single tasker,' Nye said. 'Work on one thing at a time, for a specified period of time and begin to work your way up.'
Lustig is a big fan of the 'Pomodoro technique,' in which you set a timer and work on something for 25 or 30 minutes before taking a five-minute break.
4 Experts advise focusing on one responsibility rather than multitasking.
Kalim – stock.adobe.com
She tells herself: 'I can do anything for this amount of time,' and the world will still be waiting for her at the end.
Start with something you actually like and set a goal
Advertisement
It's not enough to just have a hobby, Lustig said. It helps to choose hobbies that include deliberate practice and a goal to strive toward, whether it's playing guitar for an audience or improving in a sport.
It helps to pick something that you enjoy as well.
'You don't want to start with the heavy nonfiction or like 'War and Peace,'' Lustig said. 'If you need to start with the romance novel, then start with the romance novel. You can work your way up.'
Advertisement
It's also important to be kind to yourself. Everyone has good and bad days, and attention needs are different — and even vary from task to task.
The key is to make an intentional effort, experts say.
'It is in many ways similar to a muscle in the sense that we can build it up with practice and exercises,' Ziffra said. 'Conversely, it can weaken if we're not exercising it.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Politico
30 minutes ago
- Politico
RFK Jr.'s past claims shadow vaccine panel agenda
Presented by With help from Amanda Chu and Danny Nguyen Driving the Day ACIP AGENDA CHANGE — The agenda for next week's Advisory Committee on Immunization Practices meeting includes some notable differences from the notice posted in the Federal Register earlier this month, Sophie reports with POLITICO's Lauren Gardner. Most notably, the panel will hold two separate votes for the flu shot: one on influenza vaccines and another on influenza vaccines that contain thimerosal. In 2014, before he became health secretary, Robert F. Kennedy Jr. wrote a book in which he alleges the vaccine preservative thimerosal likely caused autism and should be banned — a claim that health agencies now under his control have said is unfounded. Thimerosal continues to be used as a preservative in multidose vaccine vials to inhibit germ growth. But its use in FDA-licensed flu vaccines has declined over the past 25 years as manufacturers reformulated their products and shifted to single-use vials. Most of those contain little or no thimerosal, according to the CDC. The meeting marks the first for Kennedy's revamped ACIP roster — following the firing of the previous 17 members — which includes several vaccine skeptics. No Covid vote: The agenda does not include a vote on Covid-19 vaccines, despite the Federal Register notice saying a vote is planned. Last month, Kennedy updated the CDC's Covid recommendations without a vote from the panel, breaking from tradition. Kennedy removed the recommendation that pregnant women get the shot, and the CDC changed the recommendation for healthy children to 'shared clinical decision making' — meaning children 'may' get vaccinated if their doctors and parents want them to. The HPV vaccine and meningococcal vaccine were also slated for a vote according to the meeting's Federal Register notice but aren't included in the draft agenda. Cut short? The agenda for the advisory committee's meeting includes only two days, June 25 and 26, but the initial Federal Register notice said the panel would also meet on June 27. A spokesperson for HHS did not comment on the thimerosal vote or why the agenda for the 27th wasn't included. WELCOME TO FRIDAY PULSE. For more on what next week's ACIP agenda holds, keep reading. Send your tips, scoops and feedback to khooper@ and sgardner@ and follow along @Kelhoops and @sophie_gardnerj. Vaccines 'THEY CROSSED THE LINE' — Dr. Fiona Havers, a CDC scientist who collected and compiled data on Covid-19 and respiratory syncytial virus before stepping down this week, told POLITICO that HHS Secretary Robert F. Kennedy Jr.'s overhaul of the agency's outside panel of vaccine experts was her final straw. 'I knew at that point that they had crossed the line,' Havers said. 'As a physician and a scientist, and for my own personal integrity, I did not feel like I could stay and legitimize this process.' The Advisory Committee on Immunization Practices votes on vaccine recommendations, playing an integral role in developing childhood and adult vaccine schedules. Last week, Kennedy fired the entire panel and replaced them with members he hand-selected. The first meeting of the new members is scheduled for next week. Havers often presented data to the panel to inform its decisions. I spoke with Havers about her decision to resign and what she will be watching for at next month's meeting. Here's our conversation, edited for length and clarity. What made you resign? [It was a] culmination over the last one to two months of RFK Jr. trashing the vaccine policy recommendation process at CDC. This has been building for a while. Several events have really undermined the vaccine policy process. One was in late May, when FDA officials released this regulatory framework suggesting that only those 65 years older and people with underlying medical conditions should receive [updated] Covid-19 vaccines. Then the following week, the HHS secretary announced on X that the Covid vaccines for healthy children and healthy pregnant women had been removed from the CDC recommended vaccine immunization schedule … Basically, RFK Jr. was making CDC vaccine policy on X without involving CDC. And that was pretty shocking, because there's a very rigorous process in place. Then last week, when they announced the firing of all 17 ACIP members, I knew I was done. Can you share any thoughts on Kennedy's replacement picks? These people are, for the most part — with very few possible exceptions — not the people that should be sitting on ACIP. What will you be watching at the meeting next week? If CDC is presenting the data … the data coming out of CDC is still solid. As of now, I can speak to the fact that the COVID-NET and RSV-NET data is high-quality evidence and can be believed. How those data get used to make vaccine policy decisions is really what's in question right now. Seeing the kind of questions that they ask and what they say may give some clue as to how they may vote in the future. I am very concerned that there's going to be a restricting of access to vaccines for people that otherwise should be getting them, and we'll get some sense of if that's actually going to happen. HHS response: HHS spokesperson Andrew Nixon told POLITICO that HHS is 'committed to following the gold standard of scientific integrity,' and 'vaccine policy decisions will be based on objective data, transparent analysis and evidence — not conflicts of interest or industry influence.' AROUND THE AGENCIES GAIN-OF-FUNCTION CUTS — The National Institutes of Health is cutting and suspending funding for gain-of-function research, a move that will impact biomedical projects conducted globally, Danny reports. The NIH's directive, released Wednesday, will immediately terminate funding and other support for gain-of-function research conducted by 'foreign entities in countries of concern or foreign countries where there is no adequate oversight.' The order didn't explicitly name the targeted groups and countries. The NIH did not respond to a request for comment. The agency will also suspend funding and additional support for all other gain-of-function research and has asked researchers who receive NIH funds to identify other projects not yet identified by the agency that fit the category by June 30. Gain-of-function research involves genetically altering biological organisms to enhance transmission or other functions, which can help scientists identify therapeutic targets. Key context: The move comes months after the Trump administration marked gain-of-function research as dangerous. Earlier this year, the administration said the Covid pandemic was caused by a lab leak from gain-of-function research at a virology research institute in the Chinese city of Wuhan, where the virus first appeared. Many scientists, however, believe the disease was caused by natural spillover from an animal to a human. The Trump administration's theory, memorialized in a glossy website unveiled in April, prompted President Donald Trump to issue an executive order last month to eliminate federal funding for gain-of-function research in countries such as China, which Trump has criticized for inadequate research oversight. The NIH's latest missive delivers on this executive order. In other research news: The FDA announced Wednesday it would immediately review new clinical trials that 'involve sending American citizens' living cells to China and other hostile countries for genetic engineering and subsequent infusion back into U.S. patients — sometimes without their knowledge or consent.' The order, endorsed by the NIH, is another swipe at foreign research — particularly studies performed in China, which the administration has characterized as poorly regulated. Industry Intel BURR'S LOBBYING GIG — The Biotechnology Innovation Organization, the world's largest biotech organization, has tapped former Republican Sen. Richard Burr (R-N.C.) to lobby on issues related to drug pricing and supply chains, Medicare and Medicaid and reauthorization of the Pandemic and All-Hazards Preparedness Act, Amanda reports. Now health policy chair at law firm DLA Piper, Burr was the top Republican on the Senate Health, Education, Labor and Pensions Committee and was a champion of reforming the FDA. Jamie Gregorian, a former senior policy adviser at the FDA and assistant to Burr in the Senate, will also represent BIO at DLA Piper, according to the law firm's disclosure submitted today. The outside hire from BIO marks the third for the group this year and comes as the biotech industry faces a steep drop in investor funding amid President Donald Trump's cuts to regulatory agencies. Earlier this week, BIO hired former Trump White House adviser Matt Mowers and Trump's campaign deputy director Bill Killion, who both now work at Valcour, a Washington-based lobbying firm. WHAT WE'RE READING POLITICO's Jordain Carney and Robert King report that Senate Republican leaders are seeking ways to tamp down moderates' worries about the megabill's possible impact on rural hospitals. The New York Times' Roni Caryn Rabin reports on the Trump administration's travel restrictions impacting medical residents.
USA Today
an hour ago
- USA Today
U.S. Open winner J.J. Spaun's health issues posed greater threat than Oakmont
U.S. Open winner J.J. Spaun's health issues posed greater threat than Oakmont As soon as J.J. Spaun won the 2025 U.S. Open at Oakmont on Sunday, Andy Bessette fired off an email to Spaun to congratulate him. 'For a man with Type 1 diabetes to win the U.S. Open with four days of pressure – pressure is the enemy of Type I diabetes – I said with your burden there is nothing more amazing than you winning the U.S. Open,' said Bessette, executive vice president and chief administrative officer at Travelers and a hammer thrower on the 1980 U.S. Olympic Team. 'To me, it's one of the greatest accomplishments in sports given the burden he lives with.' In the fall of 2018, Spaun was diagnosed with Type 2 diabetes. 'I wasn't feeling great, so I knew something was up,' he said Wednesday during his press conference ahead of the Travelers Championship in Cromwell, Connecticut. The 34-year-old started taking medicine for Type 2 but still felt lethargic, kept losing weight and, most concerning, losing distance. By mid-2021 his ranking dipped to No. 584 in the Official World Golf Ranking. Before COVID canceled the 2020 Players Championship, Bessette was chatting with pro Harold Varner III, who expressed his concern that his pal Spaun was struggling with diabetes. Bessette's son, Chris, had been diagnosed with Type I diabetes at age 18, and Bessette was familiar with the disease – the beta cells in the pancreas stop working and produce zero insulin. Spaun goes into insulin shock if he doesn't control his insulin levels. Varner called Spaun via FaceTime to connect him with Bessette, who listened to his list of symptoms. 'I said, 'Are you sure you have Type 2?' You should get yourself checked by a good endocrinologist to make sure,' Bessette recalled advising. He made some calls on Spaun's behalf to the CEO of the Juvenile Diabetes Research Foundation (since renamed Breakthrough T1D), which funds research for the development of new therapies and treatments for type 1 diabetes. Spaun eventually discovered he was misdiagnosed. 'I just was kind of going through the whole learning experience of what diabetes is and how to treat it and how to approach this disease,' Spaun said. He has been approved by the Tour to wear a Libre blood-sugar monitor and check his levels while competing. If his blood sugar is low, he can faint. If it gets too high, his vision starts to blur. Later that year at the Travelers Championship, Spaun wedged to 19 inches in a closest-to-the-pin contest at the red floating umbrella in the middle of a lake dubbed hole No. 15 ½ at TPC River Highlands. As the winner, Spaun could donate $10,000 to the charity of his choice. He chose JDRF. Bessette was touched by Spaun's gesture and personally matched the donation. 'So that initiated our connection,' Spaun said. 'He's kind of been there for me the whole way, where if it was doctors I needed to get in touch with or CEOs of JDRF, it's been nice to have that connection and his network to kind of help me along this journey because I had just been diagnosed with it, but diagnosed incorrectly. Even when I got my diagnosis corrected, I guess, it was even more so helpful to have JDRF and Andy on my side to kind of help me navigate another new territory.' Bessette was moved again Sunday when Spaun achieved a career-defining moment at Oakmont – Type I Diabetes be damned. 'It changed his life,' Bessette said of being diagnosed correctly. 'It's a brutal disease.'
Business Wire
2 hours ago
- Business Wire
Northwell's Sandra Lindsay to Be Inducted as a Fellow of the American Academy of Nursing
NEW HYDE PARK, N.Y.--(BUSINESS WIRE)--Honoring her courage during the COVID-19 pandemic and her tireless advocacy for the medical and scientific community throughout her career, Northwell Health's Sandra Lindsay, DHSc, MBA, RN, vice president of public health advocacy, has been named a Fellow of the American Academy of Nursing. The Academy is a policy organization and an honorific society that recognizes nursing's most accomplished leaders in policy, research, practice, administration and academia. On December 14, 2020, Dr. Lindsay gained international acclaim as the first person in the United States to receive the COVID-19 vaccine outside of a clinical trial. This courageous act earned her the Presidential Medal of Freedom, the nation's highest civilian honor, from President Joe Biden on July 7, 2022, along with numerous other accolades. She has since become a leading voice for scientific and clinical advocacy, global health, health equity and nursing leadership. Induction into the Academy is a significant milestone in a nurse leader's career in which their accomplishments are honored by their colleagues within and outside the profession. Fellows are selected based on their significant contributions and impact to advance the public's health. 'I am deeply honored and humbled to be inducted into the American Academy of Nursing. This recognition is not just for me, but for my entire nurse family at Northwell and beyond, who tirelessly dedicate themselves to the health and well-being of our communities,' said Dr. Lindsay. 'This fellowship affirms the vital role nurses play in shaping health care, advocating for our patients, and advancing the profession. It inspires me to continue working towards a more equitable and just health care system for all, and I am incredibly grateful for the support and encouragement I've received along the way.' Dr. Lindsay is a champion for community health and public policy, working to correct misinformation and promote both medical research and global health equity. She brings nearly three decades of nursing experience to this role, including her previous position as director of patient care services in critical care at Northwell's Long Island Jewish Medical Center. As vice president of public health advocacy and host of Northwell's award-winning 20-Minute Health Talk podcast, Dr. Lindsay has used her platform to focus on improving health care access, particularly overseas and in her homeland, Jamaica. In addition to leading clinical trips abroad, she has also championed efforts to address period poverty, ensuring young girls and women in Jamaica have access to essential menstrual supplies and resources. 'Sandra's induction into the American Academy of Nursing is a tremendous accomplishment that recognizes her extraordinary contributions,' said Maureen White, Northwell's executive vice president and chief nursing officer. 'Her career and personal achievements exemplify the power of hard work and dedication, while her unwavering commitment to the medical community, especially during and after the pandemic, has been inspiring. On behalf of Northwell Health, and particularly our dedicated nursing staff, we congratulate her on this prestigious honor.' Her writing has appeared in publications such as TIME Magazine, American Nurse Journal, and Nursing Management, and she is a sought-after speaker at international forums and events on public health topics. Dr. Lindsay also authored the memoir ' First in Line: How COVID-19 Placed Me on the Frontlines of a Health Care Crisis,' which chronicles her life's journey from her upbringing as an immigrant to becoming a prominent advocate for health equity. Dr. Lindsay immigrated to the United States from Jamaica with her siblings in 1986 to fulfill her aspiration of becoming a nurse. Her academic credentials include an associate degree in nursing from Borough of Manhattan Community College, a Bachelor of Science in nursing from St. Joseph's College, a Master of Science in nursing from Herbert Lehman College, and both a Master of Business Administration and an honorary doctorate from Hofstra University. Dr. Lindsay and the 2025 inductees will be recognized for their substantial, sustained and significant contributions to health and health care at the Academy's annual Health Policy Conference, taking place on October 16-18, 2025 in Washington, D.C., during the Induction Ceremony on the evening of October 18th. After the ceremony, the new inductees can use their FAAN (Fellow of the American Academy of Nursing) credential, the most prestigious recognition in nursing. Kerri Scanlon, MSN, RN, FAAN, Northwell's senior vice president and president of Glen Cove, Plainview and Syosset Hospitals and Ashley Graham-Perel, EdD, RN, NPD-BC, MEDSURG-BC, CNE, FADLN, FAAN, assistant professor of nursing at Columbia University sponsored Dr. Lindsay for her fellowship. The newest Fellows, were selected from a sizeable and competitive pool of applicants, represent 42 states, the District of Columbia, and 12 countries. Their unique expertise will soon bolster the collective impact of over 3,200 Academy Fellows. Academy Fellows hold a wide variety of influential roles in health care and collectively they contribute their thought leadership to develop sound policy that help to achieve the Academy's vision of healthy lives for all people. About Northwell Health Northwell is the largest not-for-profit health system in the Northeast, serving residents of New York and Connecticut with 28 hospitals, more than 1,000 outpatient facilities, 22,000 nurses and over 20,000 physicians. Northwell cares for more than three million people annually in the New York metro area, including Long Island, the Hudson Valley, western Connecticut and beyond, thanks to philanthropic support from our communities. Northwell is New York State's largest private employer with over 104,000 employees – including members of Northwell Health Physician Partners and Nuvance Health Medical Practices – who are working to change health care for the better. Northwell is making breakthroughs in medicine at the Feinstein Institutes for Medical Research. Northwell is training the next generation of medical professionals at the visionary Donald and Barbara Zucker School of Medicine at Hofstra/Northwell and the Hofstra Northwell School of Nursing and Physician Assistant Studies. For information on our more than 100 medical specialties, visit and follow us @NorthwellHealth on Facebook, X, Instagram and LinkedIn.
